Literature DB >> 24500709

Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4 (TFAP4) controls mitotic division.

Sara D'Annibale1, Jihoon Kim, Roberto Magliozzi, Teck Yew Low, Shabaz Mohammed, Albert J R Heck, Daniele Guardavaccaro.   

Abstract

TFAP4, a basic helix-loop-helix transcription factor that regulates the expression of a multitude of genes involved in the regulation of cellular proliferation, stemness, and epithelial-mesenchymal transition, is up-regulated in colorectal cancer and a number of other human malignancies. We have found that, during the G2 phase of the cell division cycle, TFAP4 is targeted for proteasome-dependent degradation by the SCF(βTrCP) ubiquitin ligase. This event requires phosphorylation of TFAP4 on a conserved degron. Expression of a stable TFAP4 mutant unable to interact with βTrCP results in a number of mitotic defects, including chromosome missegregation and multipolar spindles, which eventually lead to the activation of the DNA damage response. Our findings reveal that βTrCP-dependent degradation of TFAP4 is required for the fidelity of mitotic division.

Entities:  

Keywords:  BetaTrCP; Cell Cycle; E3 Ubiquitin Ligase; Mitosis; Protein Degradation; TFAP4; Ubiquitin

Mesh:

Substances:

Year:  2014        PMID: 24500709      PMCID: PMC3953283          DOI: 10.1074/jbc.M114.549535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Ubiquitin ligases: cell-cycle control and cancer.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

Review 2.  The SCF ubiquitin ligase: insights into a molecular machine.

Authors:  Timothy Cardozo; Michele Pagano
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

3.  SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response.

Authors:  Angelo Peschiaroli; N Valerio Dorrello; Daniele Guardavaccaro; Monica Venere; Thanos Halazonetis; Nicholas E Sherman; Michele Pagano
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

4.  Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo.

Authors:  Daniele Guardavaccaro; Yasusei Kudo; Jérôme Boulaire; Marco Barchi; Luca Busino; Maddalena Donzelli; Florence Margottin-Goguet; Peter K Jackson; Lili Yamasaki; Michele Pagano
Journal:  Dev Cell       Date:  2003-06       Impact factor: 12.270

5.  Control of epithelial cell migration and invasion by the IKKβ- and CK1α-mediated degradation of RAPGEF2.

Authors:  Roberto Magliozzi; Teck Yew Low; Bart G M W Weijts; Tianhong Cheng; Emma Spanjaard; Shabaz Mohammed; Anouk van Veen; Huib Ovaa; Johan de Rooij; Fried J T Zwartkruis; Johannes L Bos; Alain de Bruin; Albert J R Heck; Daniele Guardavaccaro
Journal:  Dev Cell       Date:  2013-11-27       Impact factor: 12.270

6.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

7.  S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.

Authors:  N Valerio Dorrello; Angelo Peschiaroli; Daniele Guardavaccaro; Nancy H Colburn; Nicholas E Sherman; Michele Pagano
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

8.  Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.

Authors:  Yoshinori Kanemori; Katsuhiro Uto; Noriyuki Sagata
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-21       Impact factor: 11.205

9.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

Authors:  Nobumoto Watanabe; Harumi Arai; Yoshifumi Nishihara; Makoto Taniguchi; Naoko Watanabe; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

10.  Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.

Authors:  Luca Busino; Maddalena Donzelli; Massimo Chiesa; Daniele Guardavaccaro; Dvora Ganoth; N Valerio Dorrello; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  Nature       Date:  2003-11-06       Impact factor: 49.962

View more
  10 in total

1.  Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.

Authors:  Yan Wang
Journal:  Pathol Oncol Res       Date:  2017-01-11       Impact factor: 3.201

2.  Degradation of Tiam1 by casein kinase 1 and the SCFβTrCP ubiquitin ligase controls the duration of mTOR-S6K signaling.

Authors:  Roberto Magliozzi; Jihoon Kim; Teck Yew Low; Albert J R Heck; Daniele Guardavaccaro
Journal:  J Biol Chem       Date:  2014-08-14       Impact factor: 5.157

3.  USP17- and SCFβTrCP--regulated degradation of DEC1 controls the DNA damage response.

Authors:  Jihoon Kim; Sara D'Annibale; Roberto Magliozzi; Teck Yew Low; Petra Jansen; Indra A Shaltiel; Shabaz Mohammed; Albert J R Heck; Rene H Medema; Daniele Guardavaccaro
Journal:  Mol Cell Biol       Date:  2014-09-08       Impact factor: 4.272

4.  DNA Damage Regulates Translation through β-TRCP Targeting of CReP.

Authors:  Theresa B Loveless; Benjamin R Topacio; Ajay A Vashisht; Shastyn Galaang; Katie M Ulrich; Brian D Young; James A Wohlschlegel; David P Toczyski
Journal:  PLoS Genet       Date:  2015-06-19       Impact factor: 5.917

5.  AP4 is required for mitogen- and c-MYC-induced cell cycle progression.

Authors:  Rene Jackstadt; Heiko Hermeking
Journal:  Oncotarget       Date:  2014-09-15

6.  Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma.

Authors:  Shuobo Boboila; Gonzalo Lopez; Jiyang Yu; Debarshi Banerjee; Angela Kadenhe-Chiweshe; Eileen P Connolly; Jessica J Kandel; Presha Rajbhandari; Jose M Silva; Andrea Califano; Darrell J Yamashiro
Journal:  Oncogene       Date:  2018-06-07       Impact factor: 9.867

7.  MicroRNA-124 suppresses the invasion and proliferation of breast cancer cells by targeting TFAP4.

Authors:  Nier Cha; Baoqing Jia; Yinzai He; Wei Luan; Wenhua Bao; Xiuhua Han; Weishi Gao; Yanwei Gao
Journal:  Oncol Lett       Date:  2021-02-09       Impact factor: 2.967

Review 8.  Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die.

Authors:  Matthew Man-Kin Wong; Sancy Mary Joyson; Heiko Hermeking; Sung Kay Chiu
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

Review 9.  Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells.

Authors:  Macarena Quiroga; Andrea Rodríguez-Alonso; Gloria Alfonsín; Juan José Escuder Rodríguez; Sara M Breijo; Venancio Chantada; Angélica Figueroa
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

10.  Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes.

Authors:  Elena Tonc; Yoshiko Takeuchi; Chun Chou; Yu Xia; Melanie Holmgren; Chika Fujii; Saravanan Raju; Gue Su Chang; Masahiro Iwamoto; Takeshi Egawa
Journal:  Blood       Date:  2021-12-16       Impact factor: 25.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.